Scarica l'app Stockscreener
4.47
2.05%
0.09
Dopo l'orario di chiusura:
4.84
0.37
+8.28%
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - AD HOC NEWS
Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance
Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
IRWD Forecast — Price Target — Prediction for 2027 - TradingView
Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView
I76 Forecast — Price Target — Prediction for 2027 - TradingView
5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance
Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan
Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ironwood Pharmaceuticals Inc - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Director Julie Mchugh Sells 21,571 Shares of Ironwood Pharmaceuticals Inc (IRWD) - GuruFocus
Ironwood Pharmaceuticals Inc (IRWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ironwood (IRWD) director Jay Shepard receives 63,481-share restricted stock grant - Stock Titan
Ironwood (NASDAQ: IRWD) director awarded restricted stock that vests before next meeting - Stock Titan
Ironwood (IRWD) director Marla Kessler receives 63,481-share restricted stock grant - Stock Titan
Ironwood Pharmaceuticals (IRWD) director receives 63,481-share grant - Stock Titan
Ironwood Pharmaceuticals (IRWD) director granted 63,481 restricted shares in latest Form 4 - Stock Titan
Ironwood (NASDAQ: IRWD) director sells shares and receives new stock grant - Stock Titan
Director Catherine Moukheibir receives 63,481 Ironwood (IRWD) restricted shares - Stock Titan
[144] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan
Ironwood Pharmaceuticals (IRWD) Jefferies London Healthcare Conference 2024 Summary - Quartr
Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026 - TradingView
Ironwood Pharmaceuticals (IRWD) retires $200M 2026 convertible notes in cash - Stock Titan
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - MSN
Ironwood Pharmaceuticals (IRWD) Tops Healthcare Sector with Stro - GuruFocus
These healthcare stocks are combining strong gains with reasonable prices (XLV:NYSEARCA) - Seeking Alpha
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026? - Yahoo Finance
· SEC Filing - MLQ.ai
IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Chart - ChartMill
IRWD: Apraglutide and LINZESS drive growth, with new trials, debt reduction, and market leadership ahead - TradingView
Ironwood Pharmaceuticals Signals Blockbuster Momentum in 2026 - The Globe and Mail
Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, News, Quote & History - Yahoo Finance
Ironwood Pharmaceuticals Expands Linzess Use and Drives Record Q1 2026 Revenue - asatunews.co.id
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess? - Insider Monkey
Ironwood (IRWD) Q1 2026 Earnings Call Transcript - The Globe and Mail
Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo
Ironwood Pharmaceuticals (IRWD) Proxy filing Summary - Quartr
Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears - MSN
IRWDIronwood Pharmaceuticals Inc Short Interest - Finviz
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2026 - BioSpace
Ironwood Pharmaceuticals to Present at Jefferies Global Healthcare Conference - geneonline.com
Ironwood Pharmaceuticals, Inc. (IRWD) stock price, news, quote and history - Yahoo Finance UK
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference - investor.ironwoodpharma.com
Ironwood Pharmaceuticals (IRWD) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
0.15%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):